Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia | Turk J Med Sci | 2021 | 33315349 | PubTator, text mining | PubMed |
| MTX Treatment Does Not Improve Outcome in Mice with AMI. | Pharmacology | 2021 | 33221800 | PubTator, text mining | PubMed |
| Systems toxicogenomics of prenatal low-dose BPA exposure on liver metabolic pathways, gut microbiota, and metabolic health in mice. | Environ Int | 2021 | 33221593 | PubTator, text mining | PubMed |
| Blood markers in remote ischaemic conditioning for acute ischaemic stroke: data from the REmote ischaemic Conditioning After Stroke Trial. | Eur J Neurol | 2021 | 33217147 | PubTator, text mining | PubMed |
| Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis. | Brain Behav | 2021 | 33210471 | PubTator, text mining | PubMed |
| Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. | Nat Immunol | 2021 | 33208929 | PubTator, text mining | PubMed |
| Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis. | J Neurochem | 2021 | 33155274 | PubTator, text mining | PubMed |
| Pentraxin 3: Potential prognostic role in SARS-CoV-2 patients admitted to the emergency department. | J Infect | 2021 | 33147434 | PubTator, text mining | PubMed |
| Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis. | Cancer Res | 2021 | 33115808 | PubTator, text mining | PubMed |
| SOCE-inhibitor reduced human sperm-induced formation of neutrophil extracellular traps. | Reproduction | 2021 | 33112289 | PubTator, text mining | PubMed |
| Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm. | Ann Hematol | 2021 | 33104881 | PubTator, text mining | PubMed |
| Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches. | J Clin Microbiol | 2021 | 33087432 | PubTator, text mining | PubMed |
| The potential value of Copeptin and Pentraxin3 for evaluating the severity of coronary stenosis in patients with coronary artery disease. | Clin Biochem | 2021 | 33080253 | PubTator, text mining | PubMed |
| New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels. | Curr Eye Res | 2021 | 33044093 | PubTator, text mining | PubMed |
| Giant Hepatomegaly with Spleno-testicular Enlargement in a Patient with Apolipoprotein A-I Amyloidosis: An Uncommon Type of Amyloidosis in Japan. | Intern Med | 2021 | 32999221 | PubTator, text mining | PubMed |
| CREBH: A Complex Array of Regulatory Mechanisms in Nutritional Signaling, Metabolic Inflammation, and Metabolic Disease. | Mol Nutr Food Res | 2021 | 32997872 | PubTator, text mining | PubMed |
| Visualizing functional dynamicity in the DNA-dependent protein kinase holoenzyme DNA-PK complex by integrating SAXS with cryo-EM. | Prog Biophys Mol Biol | 2021 | 32966823 | PubTator, text mining | PubMed |
| PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study. | J Intern Med | 2021 | 32686253 | PubTator, text mining | PubMed |
| Evaluation of Potential Antigen-specific Host Biomarkers in QuantiFERON Supernatants as Candidates for the Diagnosis of Ocular Tuberculosis. | Ocul Immunol Inflamm | 2021 | 32634059 | PubTator, text mining | PubMed |
| Association of high-risk coronary atherosclerosis at CCTA with clinical and circulating biomarkers: Insight from CAPIRE study. | J Cardiovasc Comput Tomogr | 2021 | 32563713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=43